Highly expressed levels of SLC34A2 in bladder cancer are associated with increased tumor size and lower patient survival, and depletion of SLC34A2 inhibits bladder tumor growth in vivo [103]. The gene discussed is SLC34A2; the disease is urinary bladder carcinoma.